[HTML][HTML] New antibiotics for hospital-acquired pneumonia and ventilator-associated pneumonia

M Bassetti, A Mularoni, DR Giacobbe… - … in respiratory and …, 2022 - thieme-connect.com
Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) represent
one of the most common hospital-acquired infections, carrying a significant morbidity and …

Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?

YH Ku, WL Yu - Infection, Genetics and Evolution, 2021 - Elsevier
Sulbactam, a class A β-lactamase inhibitor, added to cefoperazone either at a fixed 8 mg/L
level of sulbactam or at a level of fixed cefoperazone: sulbactam ratio (2: 1) would constitute …

[HTML][HTML] Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae

CC Chen, CC Lai, HL Huang, YT Su, YH Chiu… - Journal of Microbiology …, 2021 - Elsevier
Background This study aims to investigate the antimicrobial ability and mechanism analysis
of Lactobacillus species against carbapenemase-producing Enterobacteriaceae (CPE) …

Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms

CC Lai, CC Chen, YC Lu, TP Lin… - Infection and Drug …, 2018 - Taylor & Francis
Objectives: This study aims to assess the in vitro activity of different cefoperazone–
sulbactam ratios against different multidrug-resistant organisms (MDROs). Materials and …

Clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia

CH Chen, CY Tu, WC Chen, LK Kuo… - Infection and Drug …, 2021 - Taylor & Francis
Objective The aim of this study was to compare the usefulness of cefoperazone-sulbactam
and that of piperacillin-tazobactam in the treatment of hospital-acquired pneumonia (HAP) …

Randomized noninferiority trial of cefoperazone-sulbactam versus cefepime in the treatment of hospital-acquired and healthcare-associated pneumonia

JW Liu, YH Chen, WS Lee, JC Lin… - Antimicrobial agents …, 2019 - Am Soc Microbiol
Cefoperazone, a third-generation cephamycin with broad-spectrum antibacterial activity and
the ability to permeate bacterial cell membranes, is active against commonly encountered …

In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa

CC Lai, CC Chen, YC Lu, YC Chuang… - Infection and drug …, 2018 - Taylor & Francis
Background This study aimed to investigate the in vitro activity of cefoperazone–sulbactam
against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa, and …

Cefoperazone and sulbactam-related eosinophilic peritonitis: a case report and literature review

Z Wang, Z Li, S Luo, Z Yang, Y Xing… - Journal of …, 2021 - journals.sagepub.com
Eosinophilic peritonitis (EP) is a well-described complication of peritoneal dialysis that
occurs because of an overreaction to constituents that are related to the catheter or tubing …

Molecular characteristics and in vitro effects of antimicrobial combinations on planktonic and biofilm forms of Elizabethkingia anophelis

HJ Tang, YT Lin, CC Chen, CW Chen… - Journal of …, 2021 - academic.oup.com
Objectives To investigate the in vitro activity of antibiotics against clinical Elizabethkingia
anophelis isolates and to find a suitable antibiotic combination with synergistic effects to …

[HTML][HTML] Efficacy and safety of cefoperazone-sulbactam in empiric therapy for febrile neutropenia: A systemic review and meta-analysis

SH Lan, SP Chang, CC Lai, LC Lu, HJ Tang - Medicine, 2020 - journals.lww.com
Purpose: This meta-analysis assessed the clinical efficacy and safety of cefoperazone-
sulbactam for empiric therapy febrile neutropenia. Methods: The PubMed, Web of Science …